Manuscripts
Showing 1591 manuscripts.
Effect of pregnancy on emtricitabine pharmacokinetics
Citation
A M Stek, B M Best, W Luo, E Capparelli, S Burchett, C Hu, H Li, J S Read, A Jennings, E Barr, E Smith, S S Rossi, M Mirochnick. Effect of pregnancy on emtricitabine pharmacokinetics. HIV Medicine. 2012 Apr 01; 13(4):226-35. PMID: 22129166; PMCID: PMC3342997.Year
2012
Journal
HIV Medicine
Study
P1026S
Using cluster heat maps to investigate relationships between body composition and laboratory measurements in HIV-infected and HIV-uninfected children and young adults
Citation
Using cluster heat maps to investigate relationships between body composition and laboratory measurements in HIV-infected and HIV-uninfected children and young adults. AIDS. 2012 Mar 01; 59(3):325-328. PMID: 22083069; PMCID: PMC3288740.Year
2012
Journal
AIDS
Study
P1045
Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants
Citation
Jennifer J Kiser, Rui Zhu, David Z D'Argenio, Mark F Cotton, Raziya Bobat, George D McSherry, Shabir A Madhi, Vincent J Carey, Heiner I Seifart, Cedric J Werely, Courtney V Fletcher. Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants. Therapeutic Drug Monitoring. 2012 Aug 01; 34(4):446-451. PMID: 22695364; PMCID: PMC3397663.Year
2012
Journal
Therapeutic Drug Monitoring
Study
P1041
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals
Citation
Katherine M Knapp, Susan B Brogly, Daniel G Muenz, Hans M L Spiegel, Daniel H Conway, Gwendolyn B Scott, Jeffrey T Talbot, David E Shapiro, Jennifer S Read. Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals. Pediaric Infectious Disease Journal. 2012 Feb 01; 31(2):164-170. PMID: 21983213; PMCID: PMC3261302.Year
2012
Journal
Pediaric Infectious Disease Journal
Study
P1025
Extended prophylaxis with Nevirapine and Cotrimoxazole among HIV Exposed-Uninfected Infants is Safe
Citation
Extended prophylaxis with Nevirapine and Cotrimoxazole among HIV Exposed-Uninfected Infants is Safe. AIDS. 2012 Jan 28; 26(3):325-33. PMID: 22112598; PMCID: PMC3356697.Year
2012
Journal
AIDS
HIV disease severity and psychiatric symptomatology in perinatally HIV-infected youth.
Citation
HIV disease severity and psychiatric symptomatology in perinatally HIV-infected youth. Archives of Pediatrics and Adolescent Medicine. 2012 Jun 01; 166(6):528-35. PMID: 22312169; PMCID: PMC3407294.Year
2012
Journal
Archives of Pediatrics and Adolescent Medicine
Study
P1055
Infant Outcomes After Maternal Antiretroviral Exposure in Resource-Limited Settings
Citation
Infant Outcomes After Maternal Antiretroviral Exposure in Resource-Limited Settings. Pediatrics. 2012 Jun 01; 129(6):e1525-e1532. PMID: 22585772; PMCID: PMC3362906.Year
2012
Journal
Pediatrics
Study
P1054
Three Postpartum Antiretroviral Regimens to Prevent HIV Infection
Citation
Three Postpartum Antiretroviral Regimens to Prevent HIV Infection. New England Journal of Medicine. 2012 Jun 21; 366(25):2368-79. PMID: 22716975; PMCID: PMC3590113.Year
2012
Journal
New England Journal of Medicine
Study
P1043/HPTN 040
Safety and Immunogenicity of a Two-Dose Series of Quadrivalent Meningococcal Conjugate Vaccine in 2 to 10 Year-Old HIV-Infected Children
Citation
Safety and Immunogenicity of a Two-Dose Series of Quadrivalent Meningococcal Conjugate Vaccine in 2 to 10 Year-Old HIV-Infected Children. Pediaric Infectious Disease Journal. 2012 Jan 01; 31(1):47-52. PMID: 21987006; PMCID: PMC3252429.Year
2012
Journal
Pediaric Infectious Disease Journal
Study
P1065
Assessment of Developmental Changes in Infant Lopinavir Pharmacokinetics and its Impact on Weight Band Dosing
Citation
Assessment of Developmental Changes in Infant Lopinavir Pharmacokinetics and its Impact on Weight Band Dosing. Clinical Pharmacology & Therapeutics. 2012 Feb 01; 91(2):243-249. PMID: 22190064; PMCID: PMC3356582.Year
2012
Journal
Clinical Pharmacology & Therapeutics
Study
P1030